Borosil Scienti.

  • Market Cap: Micro Cap
  • Industry: Industrial Products
  • ISIN: INE02L001032
  • NSEID: BOROSCI
  • BSEID: 544184
INR
110.45
5.65 (5.39%)
BSENSE

Mar 18

BSE+NSE Vol: 31.31 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

31.31 k (9.80%) Volume

Shareholding (Dec 2025)

FII

0.07%

Held by 18 FIIs

DII

0.18%

Held by 0 DIIs

Promoter

67.81%

Who are the top shareholders of the Borosil Scienti.?

06-Jun-2025

The top shareholder of Borosil Scienti is Kiran Kheruka, with a 25.53% stake. Promoters hold the majority of shares, while the highest public shareholder is the Borosil Scientific Limited Unclaimed Securities Suspense Escrow Account at 2.23%.

The top shareholders of Borosil Scienti include Kiran Kheruka, who holds the highest promoter stake at 25.53%. The majority of the shares are held by promoters, with no pledged promoter holdings reported. Additionally, the highest public shareholder is the Borosil Scientific Limited Unclaimed Securities Suspense Escrow Account, which holds 2.23%. Individual investors collectively own 22.88% of the shares, while mutual funds and foreign institutional investors hold minor stakes of 0.01% and 0.24%, respectively.

View full answer

how big is Borosil Scienti.?

06-Jun-2025

As of Jun 06, Borosil Scientific Ltd has a market capitalization of 1,228.00 Cr, with net sales of 437.74 Cr and a net profit of 26.80 Cr for the latest four quarters. The company has shareholder's funds of 375.90 Cr and total assets of 488.31 Cr as of the latest annual period ending in Mar'24.

Market Cap: As of Jun 06, Borosil Scientific Ltd has a market capitalization of 1,228.00 Cr, categorizing it as a Small Cap company.<BR><BR>Recent Quarterly Performance: For the latest four quarters, Borosil Scientific Ltd reported net sales of 437.74 Cr and a net profit of 26.80 Cr. This data is consolidated.<BR><BR>Balance Sheet Snapshot: This is consolidated data for the latest annual period ending in Mar'24. The company has shareholder's funds amounting to 375.90 Cr and total assets of 488.31 Cr.

View full answer

Has Borosil Scienti. declared dividend?

06-Jun-2025

No Dividend History Available

Who are the peers of the Borosil Scienti.?

04-Jun-2025

Borosil Scienti.'s peers include Timken India, SKF India, Grindwell Norton, and others, with varying management risks and growth rates. Sejal Glass shows excellent growth and the highest 1-year return at 56.73%, while Borosil Scienti. lacks a 1-year return for comparison.

Peers: The peers of Borosil Scienti. are Timken India, SKF India, Grindwell Norton, Carborundum Uni., Borosil Renew., Sejal Glass, Rubfila Intl., Harri. Malayalam, Galaxy Bearings, and Elgi Rubber Co.<BR><BR>Quality Snapshot: Excellent management risk is observed at SKF India and Rubfila Intl., while Good management risk is found at Timken India, Grindwell Norton, and Carborundum Uni. Below Average management risk is noted at Borosil Renew., Borosil Scienti., Sejal Glass, and Elgi Rubber Co., and Average management risk is present at Harri. Malayalam. All peers exhibit Below Average growth except for Sejal Glass, which has Excellent growth, while the rest show Below Average growth. Capital Structure is Excellent for Timken India, SKF India, Grindwell Norton, Carborundum Uni., Rubfila Intl., and Galaxy Bearings, Average for Borosil Renew., Below Average for Sejal Glass, Harri. Malayalam, Elgi Rubber Co., and Borosil Scienti.<BR><BR>Return Snapshot: The peer with the highest 1-year return is Sejal Glass at 56.73%, while the lowest is Grindwell Norton at -30.27%. Borosil Scienti. does not have a 1-year return available for comparison. Additionally, the six-month return is negative for Timken India, SKF India, Grindwell Norton, Carborundum Uni., and Elgi Rubber Co.

View full answer

What does Borosil Scienti. do?

17-Jul-2025

Borosil Scientific Ltd is a small-cap company in the industrial products sector, reporting net sales of 1,295 Cr and a net profit of 87 Cr for March 2025. Key metrics include a P/E of 42.00 and a market cap of INR 1,392 Cr.

Overview:<BR>Borosil Scientific Ltd operates in the industrial products sector and is categorized as a small-cap company.<BR><BR>History:<BR>The company was originally incorporated in 1991 under the name 'Klass Pack Private Limited'. The latest quarterly results report net sales and profit for March 2025.<BR><BR>Financial Snapshot:<BR>Net Sales: 1,295 Cr (Quarterly Results - Mar 2025) <BR>Net Profit: 87 Cr (Quarterly Results - Mar 2025) <BR>Market Cap: INR 1,392 Cr (Small Cap)<BR><BR>Key Metrics:<BR>P/E: 42.00 <BR>Industry P/E: 45 <BR>Dividend Yield: 0.00% <BR>Debt-Equity: -0.01 <BR>Return on Equity: 8.79% <BR>Price to Book: 3.49 <BR><BR>Contact Details:<BR>Registrar Address: Not available. <BR>Phone: N/A <BR>Email: N/A <BR>Website: N/A

View full answer

Is Borosil Scienti. overvalued or undervalued?

19-Nov-2025

As of November 18, 2025, Borosil Scientific is considered overvalued with a PE ratio of 65.87 and has underperformed the Sensex, indicating it may be expensive compared to its peers despite being relatively more attractive than Borosil Renewables.

As of 18 November 2025, Borosil Scientific has moved from a fair to an expensive valuation grade. The company is currently considered overvalued, with a PE ratio of 65.87, an EV to EBITDA ratio of 27.83, and a Price to Book Value of 2.98. These ratios indicate that the stock is trading at a premium compared to its earnings and book value, suggesting a lack of justification for its current price level.<BR><BR>In comparison to its peers, Borosil Scientific's valuation appears high, especially when looking at Asahi India Glass, which has a PE ratio of 88, and Borosil Renewables, with a staggering PE of 216.85. While Borosil itself is categorized as expensive, it is relatively more attractive than its direct competitors like Borosil Renewables. Recent stock performance shows that Borosil has underperformed the Sensex over the past year, with a return of -22.18% compared to the Sensex's 9.48%, further reinforcing the notion that the stock may be overvalued at its current price of 135.60.

View full answer

How has been the historical performance of Borosil Scienti.?

24-Nov-2025

Borosil Scienti. showed positive financial growth from March 2024 to March 2025, with net sales increasing to 438.49 Cr, profit after tax rising to 26.72 Cr, and significant improvement in cash flow from operating activities to 120.00 Cr. Key metrics like earnings per share and operating profit margin also saw increases, indicating solid overall performance.

Answer:<BR>The historical performance of Borosil Scienti. shows a positive trend in key financial metrics from March 2024 to March 2025.<BR><BR>Breakdown:<BR>Borosil Scienti. reported net sales of 438.49 Cr in March 2025, an increase from 395.98 Cr in March 2024. The total operating income also rose to 438.49 Cr from 395.98 Cr, with raw material costs increasing to 143.54 Cr from 128.47 Cr, while the purchase of finished goods decreased slightly. Total expenditure, excluding depreciation, grew to 385.90 Cr from 349.30 Cr, leading to an operating profit (PBDIT) of 60.41 Cr, up from 50.70 Cr. Profit before tax improved to 40.39 Cr from 31.55 Cr, resulting in a profit after tax of 26.72 Cr compared to 23.48 Cr the previous year. The earnings per share increased to 3.01 from 2.65, and the operating profit margin rose to 11.99% from 11.79%. On the balance sheet, total liabilities increased to 504.34 Cr from 488.31 Cr, while total assets also grew to 504.34 Cr from 488.31 Cr. Cash flow from operating activities significantly improved to 120.00 Cr from 30.00 Cr, indicating a stronger cash position. Overall, Borosil Scienti. demonstrated growth in sales, profits, and cash flow, reflecting a solid financial performance over the year.

View full answer

Is Borosil Scienti. technically bullish or bearish?

03-Dec-2025

As of December 2, 2025, the technical trend has shifted to a bearish stance with moderate strength, supported by bearish MACD, moving averages, and Bollinger Bands, despite a mildly bullish OBV signal.

As of 2 December 2025, the technical trend has changed from mildly bearish to bearish. The current stance is bearish with moderate strength. The weekly MACD is bearish, and the daily moving averages also indicate a bearish trend. The Bollinger Bands on the weekly chart confirm this bearish outlook. Although the On-Balance Volume (OBV) shows a mildly bullish signal on the weekly timeframe, it is countered by the overall bearish indicators. The stock has underperformed significantly compared to the Sensex over multiple time frames, further supporting the bearish sentiment.

View full answer

When is the next results date for Borosil Scientific Ltd?

05-Feb-2026

The next results date for Borosil Scientific Ltd is 11 February 2026.

The next results date for Borosil Scientific Ltd is scheduled for 11 February 2026.

View full answer

Are Borosil Scientific Ltd latest results good or bad?

12-Feb-2026

Borosil Scientific Ltd's latest results show a return to profitability with a net profit of ₹10 crore in Q3 FY26, but year-on-year revenue growth is weak at 3.81%, and operating margins have significantly declined. Overall, the company's financial health is concerning due to low efficiency and underperformance compared to peers.

Borosil Scientific Ltd's latest results present a mixed picture. On one hand, the company has returned to profitability in Q3 FY26, reporting a net profit of ₹10.00 crore, a significant recovery from a loss in the previous quarter. This indicates a positive sequential turnaround.<BR><BR>However, when looking at year-on-year performance, the situation is less favorable. The company's revenue growth of 3.81% compared to the same quarter last year is considered weak, especially given the substantial decline in operating margins, which have dropped from 15.36% to 7.50%. This indicates significant operational challenges, likely driven by rising costs and pricing pressures.<BR><BR>Additionally, the return on equity (ROE) stands at a low 4.53%, suggesting poor capital efficiency. The stock has also underperformed significantly compared to its peers and the broader market, with a decline of 27.86% over the past year.<BR><BR>In summary, while the return to profitability is a positive sign, the overall financial health of Borosil Scientific is concerning due to weak growth, declining margins, and low efficiency metrics. This combination raises questions about the company's competitive positioning and ability to sustain improvements moving forward.

View full answer

Should I buy, sell or hold Borosil Scientific Ltd?

13-Feb-2026

Why is Borosil Scientific Ltd falling/rising?

17-Mar-2026

As of 16-Mar, Borosil Scientific Ltd's stock price is at 104.25, showing a slight increase today but a significant decline over various periods, including a 13.16% drop year-to-date. The stock is underperforming its sector and trading below key moving averages, indicating a bearish trend.

As of 16-Mar, Borosil Scientific Ltd's stock price is currently at 104.25, reflecting a change of 0.55 (0.53%) upward. However, despite this slight increase today, the stock has shown a significant decline over various periods. Over the past week, the stock has decreased by 2.89%, and it has fallen 13.09% over the last month. Year-to-date, the stock is down 13.16%, and it has also declined by 13.38% over the past year, contrasting sharply with the Sensex, which has increased by 2.27% in the same timeframe.<BR><BR>Today's performance indicates that Borosil Scientific Ltd has underperformed its sector by 0.33%. Additionally, the stock is trading below its moving averages across multiple time frames, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages. This suggests a bearish trend in the stock's performance. Furthermore, there has been a notable decrease in investor participation, with delivery volume falling by 13.62% compared to the 5-day average. <BR><BR>Overall, while there is a minor uptick in the stock price today, the broader context shows a consistent decline in performance, underlined by poor investor participation and trading below key moving averages, indicating that the stock is experiencing downward pressure.

View full answer
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

1

Poor Management Efficiency with a low ROE of 4.53%

  • The company has been able to generate a Return on Equity (avg) of 4.53% signifying low profitability per unit of shareholders funds
2

Poor long term growth as Net Sales has grown by an annual rate of 9.80% and Operating profit at 2.86% over the last 5 years

 
3

With ROE of 4.5, it has a Expensive valuation with a 2.3 Price to Book Value

4

Despite the size of the company, domestic mutual funds hold only 0.04% of the company

5

Below par performance in long term as well as near term

stock-summaryMojo Parameters

Mojo Parameters

Loading Valuation Snapshot...

Stock DNA

stock-summary
Industry

Industrial Products

stock-summary
Market cap

INR 982 Cr (Micro Cap)

stock-summary
P/E

39.00

stock-summary
Industry P/E

44

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.27

stock-summary
Return on Equity

4.53%

stock-summary
Price to Book

2.29

Revenue and Profits:
Net Sales:
121 Cr
(Quarterly Results - Dec 2025)
Net Profit:
9 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-6.08%
0%
-6.08%
6 Months
-20.68%
0%
-20.68%
1 Year
-9.47%
0%
-9.47%
2 Years
0%
0%
0.0%
3 Years
0%
0%
0.0%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%

Borosil Scienti. for the last several years.

Risk Adjusted Returns v/s stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryNews & Corporate Actions

News

Borosil Scientific Ltd Gains 0.53%: 5 Key Factors Driving the Week's Movement

Announcements stock-summary

Announcement under Regulation 30 (LODR)-Investor Presentation

13-Feb-2026 | Source : BSE

Investor presentation for unaudited financial results for quarter and nine months ended December 31 2025

Financial Results For The Quarter And Nine Months Ended December 31 2025

11-Feb-2026 | Source : BSE

Financial Results for the quarter and nine months ended December 31 2025

Board Meeting Outcome for Board Meeting Outcome For Financial Results For The Quarter And Nine Months Ended December 31 2025

11-Feb-2026 | Source : BSE

Financial Results for the quarter and nine months ended December 31 2025

Corporate Actions stock-summary

stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available

stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
9.80%
EBIT Growth (5y)
2.86%
EBIT to Interest (avg)
20.51
Debt to EBITDA (avg)
0.14
Net Debt to Equity (avg)
-0.27
Sales to Capital Employed (avg)
0.90
Tax Ratio
42.50%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.26%
ROCE (avg)
11.42%
ROE (avg)
4.53%

Valuation key factors

Factor
Value
P/E Ratio
39
Industry P/E
44
Price to Book Value
2.29
EV to EBIT
29.77
EV to EBITDA
17.53
EV to Capital Employed
2.76
EV to Sales
1.80
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
6.91%
ROE (Latest)
4.53%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Dow Theory
No Trend
Bearish
OBV
Bullish
Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 1 Schemes (0.01%)

FIIs

Held by 18 FIIs (0.07%)

Promoter with highest holding

Kiran Kheruka (25.52%)

Highest Public shareholder

Borosil Scientific Limited Unclaimed Securities Suspense Escrow Account (2.2%)

Individual Investors Holdings

23.06%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is 13.47% vs 11.38% in Sep 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is 200.35% vs 169.47% in Sep 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Sep'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "121.30",
          "val2": "106.90",
          "chgp": "13.47%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "17.19",
          "val2": "8.02",
          "chgp": "114.34%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.26",
          "val2": "0.23",
          "chgp": "13.04%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-1.92",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "8.68",
          "val2": "2.89",
          "chgp": "200.35%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "14.17%",
          "val2": "7.50%",
          "chgp": "6.67%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Consolidated) - Sep'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2025 is -1.90% vs 15.21% in Sep 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": " Growth in half year ended Sep 2025 is -109.18% vs 62.32% in Sep 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "202.88",
          "val2": "206.81",
          "chgp": "-1.90%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "12.90",
          "val2": "25.27",
          "chgp": "-48.95%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.61",
          "val2": "0.75",
          "chgp": "-18.67%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-6.61",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-1.27",
          "val2": "13.83",
          "chgp": "-109.18%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "6.36%",
          "val2": "12.22%",
          "chgp": "-5.86%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2025 is 5.16% vs 10.41% in Dec 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2025 is -59.13% vs 27.14% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "324.18",
          "val2": "308.26",
          "chgp": "5.16%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "30.09",
          "val2": "35.28",
          "chgp": "-14.71%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.87",
          "val2": "1.10",
          "chgp": "-20.91%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-8.53",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "7.41",
          "val2": "18.13",
          "chgp": "-59.13%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "9.28%",
          "val2": "11.44%",
          "chgp": "-2.16%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Standalone) - Mar'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2025 is 10.51% vs 9.00% in Mar 2024",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2025 is 11.32% vs 3.25% in Mar 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "Mar'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "392.49",
          "val2": "355.15",
          "chgp": "10.51%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "58.24",
          "val2": "51.08",
          "chgp": "14.02%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.78",
          "val2": "1.42",
          "chgp": "-45.07%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "35.02",
          "val2": "31.46",
          "chgp": "11.32%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "14.84%",
          "val2": "14.38%",
          "chgp": "0.46%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQstock-summary

Dec'25
Sep'25
Change(%)
Net Sales
121.30
106.90
13.47%
Operating Profit (PBDIT) excl Other Income
17.19
8.02
114.34%
Interest
0.26
0.23
13.04%
Exceptional Items
-1.92
0.00
Consolidate Net Profit
8.68
2.89
200.35%
Operating Profit Margin (Excl OI)
14.17%
7.50%
6.67%
Values in Rs Cr.
Direction Arrows
Net Sales

QoQ Growth in quarter ended Dec 2025 is 13.47% vs 11.38% in Sep 2025

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Dec 2025 is 200.35% vs 169.47% in Sep 2025

Half Yearly Results Snapshot (Consolidated) - Sep'25stock-summary

Sep'25
Sep'24
Change(%)
Net Sales
202.88
206.81
-1.90%
Operating Profit (PBDIT) excl Other Income
12.90
25.27
-48.95%
Interest
0.61
0.75
-18.67%
Exceptional Items
-6.61
0.00
Consolidate Net Profit
-1.27
13.83
-109.18%
Operating Profit Margin (Excl OI)
6.36%
12.22%
-5.86%
Values in Rs Cr.
Direction Arrows
Net Sales

Growth in half year ended Sep 2025 is -1.90% vs 15.21% in Sep 2024

Direction Arrows
Consolidated Net Profit

Growth in half year ended Sep 2025 is -109.18% vs 62.32% in Sep 2024

Nine Monthly Results Snapshot (Consolidated) - Dec'25stock-summary

Dec'25
Dec'24
Change(%)
Net Sales
324.18
308.26
5.16%
Operating Profit (PBDIT) excl Other Income
30.09
35.28
-14.71%
Interest
0.87
1.10
-20.91%
Exceptional Items
-8.53
0.00
Consolidate Net Profit
7.41
18.13
-59.13%
Operating Profit Margin (Excl OI)
9.28%
11.44%
-2.16%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2025 is 5.16% vs 10.41% in Dec 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in nine months ended Dec 2025 is -59.13% vs 27.14% in Dec 2024

Annual Results Snapshot (Standalone) - Mar'25stock-summary

Mar'25
Mar'24
Change(%)
Net Sales
392.49
355.15
10.51%
Operating Profit (PBDIT) excl Other Income
58.24
51.08
14.02%
Interest
0.78
1.42
-45.07%
Exceptional Items
0.00
0.00
Standalone Net Profit
35.02
31.46
11.32%
Operating Profit Margin (Excl OI)
14.84%
14.38%
0.46%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2025 is 10.51% vs 9.00% in Mar 2024

Direction Arrows
Standalone Net Profit

YoY Growth in year ended Mar 2025 is 11.32% vs 3.25% in Mar 2024

stock-summaryCompany CV
About Borosil Scientific Ltd stock-summary
stock-summary
Borosil Scientific Ltd
Micro Cap
Industrial Products
Borosil Scientific Limited was originally incorporated as a Private Limited Company with the name and style of `Klass Pack Private Limited' and Certificate of Incorporation dated May 29, 1991 was issued by the Registrar of Companies, Mumbai).
Company Coordinates stock-summary
Icon
No Company Details Available